UNSPSC 51391745: Isoetharine mesylate

This classification denotes a bronchodilator and beta-adrenergic agonist with the molecular formula C13H21NO3.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DV74WJ5PJB, chemically known as 3,4-dihydroxy-alpha-(1-(isopropylamino)propyl)benzyl alcohol methanesulfonate (salt) but more generally known as isoetarine mesilate, which bears U.S. National Institutes of Health Compound Identifier 23702.

UNSPSC 51391745 Isoetharine mesylate is a Commodity code that covers pharmaceutical products and respiratory medications. However, the recent state and local opportunities tagged under this code show a significant mismatch with the code's nominal scope. The Seminole County, Florida IFB solicitation primarily targets naloxone and safe drug deactivation systems—opioid antagonists and harm-reduction equipment rather than isoetharine mesylate, a bronchodilator medication. The Texas Health and Human Services Commission RFI addresses direct-to-manufacturer prescription program capabilities across a broader pharmacy benefit landscape, not isoetharine mesylate specifically. State and local procurement bodies posting under this code appear to include county health departments and state health and human services agencies, though the recent activity is too sparse to characterize a clear issuing-body pattern.

Geographic activity is limited to two states in the recent record. Seminole County, Florida posted an IFB on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 (note: the posted date and response deadline conflict internally in the source). Texas HHS Commission issued an RFI on April 3, 2026, regarding direct-to-manufacturer prescription capabilities with the same response date. The code shows minimal recent relevant activity and does not appear to reflect active state and local procurement for isoetharine mesylate itself.